Collectively, our results suggest that LASP1 phosphorylation might serve as an additional candidate biomarker for assessment of BCR-ABL activity and provide a first step toward a molecular understanding of LASP1 function in CML. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.